Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
In brief: A new non-small cell lung cancer indication for osimertinib (Tagrisso). 简而言之奥西替尼(Tagrisso)新增非小细胞肺癌适应症。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715h
{"title":"In brief: A new non-small cell lung cancer indication for osimertinib (Tagrisso).","authors":"","doi":"10.58347/tml.2024.1715h","DOIUrl":"https://doi.org/10.58347/tml.2024.1715h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1715","pages":"e190-e191"},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: FluMist influenza vaccine for self-administration. 简而言之:用于自我注射的 FluMist 流感疫苗。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714c
{"title":"In brief: FluMist influenza vaccine for self-administration.","authors":"","doi":"10.58347/tml.2024.1714c","DOIUrl":"https://doi.org/10.58347/tml.2024.1714c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1714","pages":"174-175"},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 update: Novavax vaccine for 2024-2025. COVID-19 更新:2024-2025 年的 Novavax 疫苗。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714d
{"title":"COVID-19 update: Novavax vaccine for 2024-2025.","authors":"","doi":"10.58347/tml.2024.1714d","DOIUrl":"https://doi.org/10.58347/tml.2024.1714d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1714","pages":"175-176"},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: Subcutaneous ocrelizumab (Ocrevus Zunovo) for multiple sclerosis. 简而言之治疗多发性硬化症的皮下注射奥克雷珠单抗(Ocrevus Zunovo)。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714b
{"title":"In brief: Subcutaneous ocrelizumab (Ocrevus Zunovo) for multiple sclerosis.","authors":"","doi":"10.58347/tml.2024.1714b","DOIUrl":"https://doi.org/10.58347/tml.2024.1714b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1714","pages":"174"},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for hepatitis C virus infection. 治疗丙型肝炎病毒感染的药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714a
{"title":"Drugs for hepatitis C virus infection.","authors":"","doi":"10.58347/tml.2024.1714a","DOIUrl":"https://doi.org/10.58347/tml.2024.1714a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1714","pages":"169-174"},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Figure 1: Treatment of hepatitis C virus infection in treatment-naive adults. 图 1:治疗未接受治疗的成人丙型肝炎病毒感染。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714e
{"title":"Figure 1: Treatment of hepatitis C virus infection in treatment-naive adults.","authors":"","doi":"10.58347/tml.2024.1714e","DOIUrl":"https://doi.org/10.58347/tml.2024.1714e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1714","pages":"e174"},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Table 3: Some drug interactions with DAAs for HCV infection. 表 3:与治疗 HCV 感染的 DAAs 的一些药物相互作用。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714f
{"title":"Table 3: Some drug interactions with DAAs for HCV infection.","authors":"","doi":"10.58347/tml.2024.1714f","DOIUrl":"https://doi.org/10.58347/tml.2024.1714f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1714","pages":"e175"},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lazertinib (Lazcluze) for non-small cell lung cancer. 治疗非小细胞肺癌的 Lazertinib(Lazcluze)。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714g
{"title":"Lazertinib (Lazcluze) for non-small cell lung cancer.","authors":"","doi":"10.58347/tml.2024.1714g","DOIUrl":"https://doi.org/10.58347/tml.2024.1714g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1714","pages":"e176-e177"},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addendum: Effectiveness of mRNA COVID-19 vaccines. 增编:mRNA COVID-19 疫苗的有效性。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-14 DOI: 10.58347/tml.2024.1713h
{"title":"Addendum: Effectiveness of mRNA COVID-19 vaccines.","authors":"","doi":"10.58347/tml.2024.1713h","DOIUrl":"10.58347/tml.2024.1713h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1713","pages":"e168"},"PeriodicalIF":1.4,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for plaque psoriasis. 治疗斑块状银屑病的药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-09-30 DOI: 10.58347/tml.2024.1712a
{"title":"Drugs for plaque psoriasis.","authors":"","doi":"10.58347/tml.2024.1712a","DOIUrl":"10.58347/tml.2024.1712a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1712","pages":"153-160"},"PeriodicalIF":1.4,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信